CellMed AG to Use Scarab Genomics’s Clean Genome E. coli in the Production of a New Medical Product

Published: Apr 07, 2011

MADISON, Wis.--(BUSINESS WIRE)--Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics’ Clean Genome E. coli Technology in a new product development in the life science field.

Back to news